200 related articles for article (PubMed ID: 23441645)
21. Contrast-enhanced ultrasound identifies reduced overall and regional renal perfusion during global hypoxia in piglets.
Brabrand K; de Lange C; Emblem KE; Reinholt FP; Saugstad OD; Stokke ES; Munkeby BH
Invest Radiol; 2014 Aug; 49(8):540-6. PubMed ID: 24637585
[TBL] [Abstract][Full Text] [Related]
22. Computed tomography and low-field magnetic resonance imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism: 11 cases (2001-2003).
Auriemma E; Barthez PY; van der Vlugt-Meijer RH; Voorhout G; Meij BP
J Am Vet Med Assoc; 2009 Aug; 235(4):409-14. PubMed ID: 19681723
[TBL] [Abstract][Full Text] [Related]
23. The efficacy of L-Deprenyl in dogs with pituitary-dependent hyperadrenocorticism.
Reusch CE; Steffen T; Hoerauf A
J Vet Intern Med; 1999; 13(4):291-301. PubMed ID: 10449218
[TBL] [Abstract][Full Text] [Related]
24. Use of contrast-enhanced ultrasonography to characterize adrenal gland tumors in dogs.
Pey P; Rossi F; Vignoli M; Duchateau L; Marescaux L; Saunders JH
Am J Vet Res; 2014 Oct; 75(10):886-92. PubMed ID: 25255177
[TBL] [Abstract][Full Text] [Related]
25. Trabecular bone morphometry in beagles with hyperadrenocorticism and adrenal adenomas.
Norrdin RW; Carpenter TR; Hamilton BF; Brewster RD
Vet Pathol; 1988 Jul; 25(4):256-64. PubMed ID: 3407096
[TBL] [Abstract][Full Text] [Related]
26. Quantitative evaluation of canine urinary bladder transitional cell carcinoma using contrast-enhanced ultrasonography.
Macrì F; Di Pietro S; Mangano C; Pugliese M; Mazzullo G; Iannelli NM; Angileri V; Morabito S; De Majo M
BMC Vet Res; 2018 Mar; 14(1):84. PubMed ID: 29530040
[TBL] [Abstract][Full Text] [Related]
27. Use of low- and high-dose dexamethasone tests for distinguishing pituitary-dependent from adrenal tumor hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS
J Am Vet Med Assoc; 1996 Aug; 209(4):772-5. PubMed ID: 8756877
[TBL] [Abstract][Full Text] [Related]
28. Comparison of mitotane treatment for adrenal tumor versus pituitary-dependent hyperadrenocorticism in dogs.
Feldman EC; Nelson RW; Feldman MS; Farver TB
J Am Vet Med Assoc; 1992 Jun; 200(11):1642-7. PubMed ID: 1320600
[TBL] [Abstract][Full Text] [Related]
29. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995).
Van Liew CH; Greco DS; Salman MD
J Am Vet Med Assoc; 1997 Aug; 211(3):322-5. PubMed ID: 9262671
[TBL] [Abstract][Full Text] [Related]
30. Imaging of the pituitary gland in dogs with pituitary-dependent hyperadrenocorticism.
van der Vlugt-Meijer RH; Voorhout G; Meij BP
Mol Cell Endocrinol; 2002 Nov; 197(1-2):81-7. PubMed ID: 12431800
[TBL] [Abstract][Full Text] [Related]
31. Use of endogenous ACTH concentration and adrenal ultrasonography to distinguish the cause of canine hyperadrenocorticism.
Gould SM; Baines EA; Mannion PA; Evans H; Herrtage ME
J Small Anim Pract; 2001 Mar; 42(3):113-21. PubMed ID: 11303853
[TBL] [Abstract][Full Text] [Related]
32. Use of aminoglutethimide in the treatment of pituitary-dependent hyperadrenocorticism in the dog.
Pérez AM; Guerrero B; Melián C; Ynaraja E; Peña L
J Small Anim Pract; 2002 Mar; 43(3):104-8. PubMed ID: 11924551
[TBL] [Abstract][Full Text] [Related]
33. Pulsatile secretion pattern of growth hormone in dogs with pituitary-dependent hyperadrenocorticism.
Lee WM; Meij BP; Bhatti SF; Mol JA; Rijnberk A; Kooistra HS
Domest Anim Endocrinol; 2003 Jan; 24(1):59-68. PubMed ID: 12450625
[TBL] [Abstract][Full Text] [Related]
34. Pheochromocytoma and hyperadrenocorticism in dogs: six cases (1982-1992).
von Dehn BJ; Nelson RW; Feldman EC; Griffey SM
J Am Vet Med Assoc; 1995 Aug; 207(3):322-4. PubMed ID: 7628933
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of canine hyperadrenocorticism, using computed tomography.
Emms SG; Wortman JA; Johnston DE; Goldschmidt MH
J Am Vet Med Assoc; 1986 Aug; 189(4):432-9. PubMed ID: 3019972
[TBL] [Abstract][Full Text] [Related]
36. Hyperadrenocorticism caused by bilateral adrenocortical neoplasia in dogs: four cases (1983-1988).
Ford SL; Feldman EC; Nelson RW
J Am Vet Med Assoc; 1993 Mar; 202(5):789-92. PubMed ID: 8454518
[TBL] [Abstract][Full Text] [Related]
37. Quantitative, noninvasive assessment of intra- and extraocular perfusion by contrast-enhanced ultrasonography and its clinical applicability in healthy dogs.
Blohm KO; Hittmair KM; Tichy A; Nell B
Vet Ophthalmol; 2019 Nov; 22(6):767-777. PubMed ID: 30773789
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two low-dose dexamethasone suppression protocols as screening and discrimination tests in dogs with hyperadrenocorticism.
Mack RE; Feldman EC
J Am Vet Med Assoc; 1990 Dec; 197(12):1603-6. PubMed ID: 2177458
[TBL] [Abstract][Full Text] [Related]
39. Quantitative CT assessment of bone mineral density in dogs with hyperadrenocorticism.
Lee D; Lee Y; Choi W; Chang J; Kang JH; Na KJ; Chang DW
J Vet Sci; 2015; 16(4):531-42. PubMed ID: 26040613
[TBL] [Abstract][Full Text] [Related]
40. Effects of size and location of regions of interest examined by use of contrast-enhanced ultrasonography on renal perfusion variables of dogs.
Macrì F; Di Pietro S; Liotta L; Piccionello AP; Pugliese M; De Majo M
Am J Vet Res; 2016 Aug; 77(8):869-76. PubMed ID: 27463550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
